References
- Lau TK, Cheung SW, Lo PS, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol. 2014;43(3):254–264.
- Screening for Fetal Chromosomal Abnormalities. ACOG Practice Bulletin. 2020;226:e1–e22.
- Dondorp W, de Wert G, Bombard Y, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet. 2015;23(11):1438–1450.
- Wang Y, Li S, Wang W, et al. Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma. Mol Cytogenet. 2020;13:10.
- Margiotti K, Cesta A, Dello Russo C, et al. Cell-free DNA screening for sex chromosomal aneuploidies in 9985 pregnancies: Italian single experience. BMC Res Notes. 2020;13(1):167.
- Wan J, Li R, Zhang Y, et al. Pregnancy outcome of autosomal aneuploidies other than common trisomies detected by noninvasive prenatal testing in routine clinical practice. Prenat Diagn. 2018;38(11):849–857.
- He Y, Liu Y-H, Xie R-G, et al. Rare autosomal trisomies on non-invasive prenatal testing: not as adverse as expected. Ultrasound Obstet Gynecol. 2019;54(6):838–839.
- Suo F, Wang C, Liu T, et al. Non-invasive prenatal testing in detecting sex chromosome aneuploidy: a large-scale study in xuzhou area of China. Clin Chim Acta. 2018;481:139–141.
- Zheng Y, Wan S, Dang Y, et al. Clinical experience regarding the accuracy of NIPT in the detection of sex chromosome abnormality. J Gene Med. 2020;22(8):199.
- Kornman L, Palma-Dias R, Nisbet D, et al. Non-invasive prenatal testing for sex chromosome aneuploidy in routine clinical practice. Fetal Diagn Ther. 2018;44(2):85–90.
- Jiang F, Ren J, Chen F, et al. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics. 2012;5:57.
- Liao C, Yang X, Li F-T, et al. The detection of aneuploidy and maternal contamination by QF-PCR in samples undergoing prenatal diagnosis for thalassemia in Southern China. Eur J Obstet Gynecol Reprod Biol. 2009;144(2):149–152.
- Liang D, Cram DS, Tan H, et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med. 2019;21(9):1998–2006.
- Luo X, Hu L, Pei Y, et al. Prenatal diagnosis and pregnancy determination of sex chromosome aneuploidy screened by non-invasive prenatal testing from 52,453 unselected singleton pregnancies: a retrospective analysis of 4-year experience. 07 February 2020. PREPRINT (Version 2) available at Research square.
- Deng C, Zhu Q, Liu S, et al. Clinical application of noninvasive prenatal screening for sex chromosome aneuploidies in 50,301 pregnancies: initial experience in a chinese hospital. Sci Rep. 2019;9(1):1–8.
- Xue Y, Zhao G, Li H, et al. Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies. Mol Cytogenet. 2019;12:29.
- Xu Y, Chen L, Liu Y, et al. Screening, prenatal diagnosis, and prenatal decision for sex chromosome aneuploidy. Expert Rev Mol Diagn. 2019;19(6):537–542.
- Bevilacqua E, Ordóñez E, Hurtado I, et al. Screening for sex chromosome aneuploidy by Cell-Free DNA testing: patient choice and performance. Fetal Diagn Ther. 2017;44(2):1–7.
- Xu L, Huang H, Lin N, et al. Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China. Ultrasound Obstet Gynecol. 2020;55(2):242–247.
- Wang Y, Chen Y, Tian F, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem. 2014;60(1):251–259.
- Linden MG, Bender BG, Robinson A. Genetic counseling for sex chromosome abnormalities. Am J Med Genet. 2002;110(1):3–10.
- Ottesen AM, Aksglaede L, Garn I, et al. Increased number of sex chromosomes affects height in a nonlinear fashion: a study of 305 patients with sex chromosome aneuploidy. Am J Med Genet. 2010;152A(5):1206–1212.
- Papoulidis I, Siomou E, Sotiriadis A, et al. Dual testing with QF-PCR and karyotype analysis for prenatal diagnosis of chromosomal abnormalities. Evaluation of 13,500 cases with consideration of using QF-PCR as a stand-alone test according to referral indications. Prenat Diagn. 2012;32(7):680–685.
- Cirigliano V, Voglino G, Marongiu A, et al. Rapid prenatal diagnosis by QF-PCR: evaluation of 30,000 consecutive clinical samples and future applications. Ann N Y Acad Sci. 2006;1075:288–298.
- Shi Y, Li X, Ju D, et al. Efficiency of noninvasive prenatal testing for sex chromosome aneuploidies. Gynecol Obstet Invest. 2021;86(4):379–387.
- Zhang B, Zhou Q, Chen Y, et al. High false-positive non-invasive prenatal screening results for sex chromosome abnormalities: are maternal factors the culprit? Prenat Diagn. 2020;40(4):463–469.
- Yuan P, Zhang B, Liu J, et al. Influence of maternal chromosomal abnormalities on non-invasive prenatal testing for fetal sex chromosome aneuploidies. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020;37(6):617–620.